Company DelMar Pharmaceuticals Inc Nasdaq
Equities
US2470782077
Biotechnology & Medical Research
Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
Robert Hoffman
CEO | Chief Executive Officer | 58 | 18-04-10 |
Greg Johnson
COO | Chief Operating Officer | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Robert Hoffman
CEO | Chief Executive Officer | 58 | 18-04-10 |
Tamara Favorito
BRD | Director/Board Member | 65 | 21-04-28 |
Laura Douglass
BRD | Director/Board Member | 59 | 20-06-25 |
Robert Toth
BRD | Director/Board Member | 60 | 13-08-19 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 0 | 14,000 | 0 | 0 | 99.81 % |
Stock B | 1 | 39,037,899 | 38,961,784 ( 99.81 %) | 0 | |
Stock C | 0 | 279,000 | 0 | 0 |
Company contact information
Kintara Therapeutics, Inc.
9920 Pacific Heights Boulevard Suite 150
92121, San Diego
+858 350 4364
http://www.kintara.comSector
1st Jan change | Capi. | |
---|---|---|
-2.31% | 103B | |
+0.56% | 95.28B | |
+1.69% | 22.15B | |
-17.37% | 21.02B | |
-9.30% | 18.15B | |
-41.01% | 16.73B | |
-14.85% | 16.05B | |
+3.21% | 13.68B | |
+33.54% | 12.17B |